These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5114583)

  • 21. [Betanidine (Esbatal, Regulin) in the therapy of hypertension].
    Vejlsgaard V
    Ugeskr Laeger; 1968 Jan; 130(4):134-6. PubMed ID: 5674763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficacy of guanfacine in the treatment of arterial hypertension].
    de Broucker D; Graux P; Dutoit A; Croccel L
    LARC Med; 1982; 2(7):613-5. PubMed ID: 6762476
    [No Abstract]   [Full Text] [Related]  

  • 23. [Guanfacine: controlled clinical study in arterial hypertension].
    Lauro R
    Clin Ter; 1980 May; 93(4):439-55. PubMed ID: 6998644
    [No Abstract]   [Full Text] [Related]  

  • 24. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine].
    Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W
    Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 26. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and tolerability of the herbal mixture Asparagus P on blood pressure in treatment-requiring antihypertensives.
    Chrubasik S; Droste C; Dragano N; Glimm E; Black A
    Phytomedicine; 2006 Nov; 13(9-10):740-2. PubMed ID: 16488123
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cyclazenin in the treatment of arterial hypertension].
    Salvetti A; Romanelli R
    Policlinico Prat; 1969 Jun; 76(24):777-82. PubMed ID: 5404717
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical trial of guanoxan alone and in combination with polythiazide in hypertension.
    Dave BT; Munsi CP; Bhakta RD; Parikh HM; Gulati OD
    Indian Heart J; 1970 Apr; 22(2):83-94. PubMed ID: 5524437
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trial of compound 1029 (vatensol).
    Srivastava BN; Gupta RK; Harshvardhan ; Goswami SL
    Indian Heart J; 1966 Oct; 18(4):333-44. PubMed ID: 5977540
    [No Abstract]   [Full Text] [Related]  

  • 31. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of arterial hypertension with polythiazide and guanoxan].
    Froment A; Vallese J
    Lyon Med; 1969 Mar; 221(10):523-7. PubMed ID: 5357282
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
    Schäfer N; Knaup G
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):249-52. PubMed ID: 6806612
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends in the treatment of hypertension.
    Wasir HS; Agarwal R
    J Assoc Physicians India; 1993 Nov; 41(11):725-30. PubMed ID: 8005931
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical pharmacology of the newer antihypertensive agents].
    Rahn KH
    Internist (Berl); 1983 Mar; 24(3):128-34. PubMed ID: 6347939
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.